The effective components of the mRNA vaccine are all encapsulated in lipid nanoparticles (LNPs), which protect the mRNA from degradation and can also efficiently complete the intracellular delivery of mRNA. Lipid nanoparticles mainly contain four components: ionizable lipids, neutral auxiliary lipids, cholesterol, and PEGylated lipids. PEG can enhance the stability and life of LNPs.
SINOPEG has taken the lead in realizing the commercial production of LNP delivery materials in China. At present, the company has a variety of mRNA vaccine lipid excipients with independent intellectual property rights, and can be customized according to customer entrustment. Many of our products (including customized structures) have been verified by many mRNA vaccine manufacturers and have completed quality research data.
SINOPEG has taken the lead in realizing the commercial production of LNP delivery materials in China. At present, the company has a variety of mRNA vaccine lipid excipients with independent intellectual property rights, and can be customized according to customer entrustment. Many of our products (including customized structures) have been verified by many mRNA vaccine manufacturers and have completed quality research data.
